CLSD News
Archived Headlines
- US IPO Week ahead: Four more IPOs set up May 2016 to be most active month YTD 05/13/16
- Blindness biotech Clearside Biomedical sets terms for $60 million IPO 05/11/16
- US IPO Weekly Recap: 2016 IPO market kicks off with a flurry of biotech filings 01/08/16
- Phase 3 in Sight: Clearside Biomedical files for a $58 million IPO 01/08/16
US IPO Weekly Recap: Three healthcare IPOs led by billionaire-backed NantHealth's +33% pop
The shortened holiday week saw three healthcare IPOs raise over $150 million, bringing the year-to-date total up to 34 offerings. Can't stop Nant: NantHealth surges 33% in year's second-best IPO debut Billionaire founder and CEO Patrick...read more
Eyes on the IPO prize: Clearside Biomedical prices upsized IPO below original range at $7
Clearside Biomedical, which is developing a combination drug-device therapy for eye diseases, raised $50 million by offering 7.2 million shares at $7, as expected. The company revised the terms of the deal on Wednesday; it originally planned to raise $60 million...read more
Watch out! Clearside Biomedical slashes proposed IPO price to $7
Clearside Biomedical, which is developing a combination drug-device therapy for eye diseases, lowered the proposed deal size for its upcoming IPO on Wednesday. The Alpharetta, GA-based company now plans to raise $50 million by offering 7.2 million shares at...read more
US IPO Week Ahead: Six IPOs cap off a busy May as US Foods seeks $1 billion
The year's most active week by deal count and proceeds is set to cap off the year's busiest month: The ...read more